Stratec Biomedical AG Stock Xetra
Equities
DE0007289001
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- EUR | - |
11:30am | STRATEC BIOMEDICAL SYSTEMS AG : Warburg Research remains Neutral | ZD |
10:12am | Stratec sees revival in second quarter - share price jumps | DP |
Sales 2024 * | 274M 293M | Sales 2025 * | 297M 318M | Capitalization | 488M 523M |
---|---|---|---|---|---|
Net income 2024 * | 19M 20.37M | Net income 2025 * | 25M 26.81M | EV / Sales 2024 * | 2.15 x |
Net Debt 2024 * | 101M 108M | Net Debt 2025 * | 75.86M 81.34M | EV / Sales 2025 * | 1.9 x |
P/E ratio 2024 * |
24.5
x | P/E ratio 2025 * |
18.9
x | Employees | - |
Yield 2024 * |
2% | Yield 2025 * |
2.26% | Free-Float | 59.43% |
Latest transcript on Stratec Biomedical AG
Managers | Title | Age | Since |
---|---|---|---|
Marcus Wolfinger
CEO | Chief Executive Officer | 56 | 98-02-28 |
Robert Siegle
DFI | Director of Finance/CFO | 56 | 98-04-30 |
Jan Keppeler
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Hiller
BRD | Director/Board Member | 57 | 19-05-28 |
Georg Heni
CHM | Chairman | 66 | 22-05-19 |
Rolf Vornhagen
BRD | Director/Board Member | 70 | 20-07-20 |
1st Jan change | Capi. | |
---|---|---|
+7.71% | 218B | |
+6.25% | 182B | |
+10.60% | 132B | |
+26.73% | 108B | |
-0.38% | 62.51B | |
+15.42% | 52.98B | |
-1.89% | 47.59B | |
-1.91% | 39.96B | |
+11.16% | 39.22B |